Targeting Cardiac Fibroblasts to Treat Fibrosis of the Heart: Focus on HDACs

Journal of Molecular and Cellular Cardiology - United States
doi 10.1016/j.yjmcc.2014.02.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Progress and Challenge of Cardiac Regeneration to Treat Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Cardiac Fibroblasts: At the Heart of Myocardial Remodeling

Pharmacology and Therapeutics
Pharmacology
2009English

Targeting Obesity and Diabetes to Treat Heart Failure With Preserved Ejection Fraction

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Effect of Efonidipine on TGF-β1–Induced Cardiac Fibrosis Through Smad2-Dependent Pathway in Rat Cardiac Fibroblasts

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2011English

Author Correction: Targeting Cardiac Fibrosis With Engineered T Cells

Nature
Multidisciplinary
2019English

Focus on Idiopathic Pulmonary Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

BNIP3L Promotes Cardiac Fibrosis in Cardiac Fibroblasts Through [Ca2+]i-TGF-Β-Smad2/3 Pathway

Scientific Reports
Multidisciplinary
2017English

Functional Alterations of Ion Channels From Cardiac Fibroblasts in Heart Diseases

Journal of Patient-Centered Research and Reviews
2016English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy